Global reach. Advanced sterile manufacturing capabilities. Fresenius Kabi Contract Manufacturing provides access to a network of 17+ development and manufacturing facilities for sterile pharmaceuticals worldwide. Across our three U.S. manufacturing sites, we offer vial, IV bag and prefilled syringe fill-finish capabilities, including FDA-approved high potency and cytotoxic isolator filling lines. Our teams work closely with customers to identify the right technology and production approach for their products. Explore our capabilities: cmo.fresenius-kabi.com #ContractManufacturing #FocusedOnYourSuccess

Your three U.S. manufacturing sites equipped with FDA-approved high potency and cytotoxic isolator filling lines represent a significant operational scale in sterile pharmaceuticals. How do you integrate these advanced fill-finish capabilities with your broader enterprise IT stack—specifically around API orchestration, OPC-UA middleware, or ERP synchronization across your global facility network? My team specializes in eliminating data silos by building custom full-stack middleware using Python and FastAPI over PostgreSQL, and I'd love to share our architecture patterns with you.

Like
Reply

Impressive to see aseptic, and sterile technology at global platforms enhancing and providing solution to customers and patients. WELDONE Fresinous✓

Like
Reply
See more comments

To view or add a comment, sign in

Explore content categories